These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 12794762
1. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, Riboli E, Seidell JC, Grobbee DE, Peeters PH. Int J Cancer; 2003 Aug 10; 106(1):90-5. PubMed ID: 12794762 [Abstract] [Full Text] [Related]
2. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE. Cancer Epidemiol Biomarkers Prev; 2005 Mar 10; 14(3):699-704. PubMed ID: 15767352 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Endocr Relat Cancer; 2006 Jun 10; 13(2):583-92. PubMed ID: 16728584 [Abstract] [Full Text] [Related]
4. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA, Borofsky ND, Massardo S, Orentreich N. Cancer Epidemiol Biomarkers Prev; 2002 Dec 10; 11(12):1566-73. PubMed ID: 12496045 [Abstract] [Full Text] [Related]
5. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. Lukanova A, Toniolo P, Akhmedkhanov A, Biessy C, Haley NJ, Shore RE, Riboli E, Rinaldi S, Kaaks R. Int J Cancer; 2001 Jun 15; 92(6):888-92. PubMed ID: 11351312 [Abstract] [Full Text] [Related]
7. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Lancet; 1998 May 09; 351(9113):1393-6. PubMed ID: 9593409 [Abstract] [Full Text] [Related]
8. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R. Int J Cancer; 2004 Jan 10; 108(2):262-8. PubMed ID: 14639613 [Abstract] [Full Text] [Related]
9. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG. Cancer Epidemiol Biomarkers Prev; 2007 Apr 10; 16(4):763-8. PubMed ID: 17416768 [Abstract] [Full Text] [Related]
10. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH. Cancer Causes Control; 2004 Oct 10; 15(8):787-96. PubMed ID: 15456992 [Abstract] [Full Text] [Related]
11. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME. Int J Cancer; 2004 Feb 20; 108(5):773-9. PubMed ID: 14696106 [Abstract] [Full Text] [Related]
12. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark. Kalledsøe L, Dragsted LO, Hansen L, Kyrø C, Grønbæk H, Tjønneland A, Olsen A. Growth Horm IGF Res; 2019 Feb 20; 44():33-42. PubMed ID: 30622040 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Diorio C, Pollak M, Byrne C, Mâsse B, Hébert-Croteau N, Yaffe M, Coté G, Bérubé S, Morin C, Brisson J. Cancer Epidemiol Biomarkers Prev; 2005 May 20; 14(5):1065-73. PubMed ID: 15894654 [Abstract] [Full Text] [Related]
14. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E. J Natl Cancer Inst; 2000 Oct 04; 92(19):1592-600. PubMed ID: 11018095 [Abstract] [Full Text] [Related]
16. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S, Japan Public Health Center-based Prospective Study Group. Int J Cancer; 2007 May 01; 120(9):2007-12. PubMed ID: 17266031 [Abstract] [Full Text] [Related]
18. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ. Gynecol Endocrinol; 2005 Mar 01; 20(3):176-82. PubMed ID: 16019358 [Abstract] [Full Text] [Related]
19. Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC, Sun CA. Int J Cancer; 2010 Jan 15; 126(2):508-14. PubMed ID: 19585556 [Abstract] [Full Text] [Related]
20. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P. Cancer Epidemiol Biomarkers Prev; 2005 Jan 15; 14(1):48-52. PubMed ID: 15668475 [Abstract] [Full Text] [Related] Page: [Next] [New Search]